SBI Securities »

Entero Therapeutics shares owned by SBI Securities

Quarter-by-quarter ownership of Entero Therapeutics shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Entero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entero Therapeutics held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entero Therapeutics by SBI Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.8k 553 5.00

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Tesla Motors (TSLA)
Apple (AAPL)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
Vanguard Total World Stock ETF Etf (VT)
Amazon (AMZN)
Vanguard High Dividend Yield ETF Etf (VYM)
Alphabet Inc Class A cs (GOOGL)
SPDR Portfolio S&P500 HighDividend ETF Etf (SPYD)
Facebook Inc cl a (META)
Direxion Daily Semi Bull 3X Etf (SOXL)

View all positions for SBI Securities

Top funds holding Entero Therapeutics

Renaissance Technologies
Vanguard Group
State Street Corporation
Geode Capital Management
Virtu Financial
SBI Securities
UBS Group
Danske Bank A/s

View all funds holding Entero Therapeutics